MFA Blog

OTC Derivatives Update Highlights Panel Discussion at MFA’s Compliance 2014

Posted on May 7, 2014

MFA’s Compliance 2014 conference neared its completion this afternoon with a discussion updating participants on a number of issues surrounding OTC derivatives.  Kim Rozman, Associate General Counsel, HBK Capital Management moderated the discussion.  Panelists included Stephen Berger, Director, Government and Regulatory Policy, Citadel LLC; Brian A. Bussey, Associate Director for Derivatives Policy and Trading Practices, Division of Trading and Markets, U.S. Securities and Exchange Commission; Steven Lofchie, Partner, Cadwalader Wickersham & Taft; and Scott Reinhart, Co-Chief of Staff and Co-Chief Operating Officer, U.S. Commodity Futures Trading Commission.

Topics, among others, covered by the panel included cross-border regulation, timing of upcoming SEC and CFTC derivatives rulemaking, equivalence under the different derivatives reforms, and capital and margin requirements for uncleared swaps.  Panelists stressed the importance of harmonization of rules among various regulators, with panelists noting the possible implications of duplicative or conflicting regulations.  The discussion also covered different issues associated with EMIR.

This concludes MFA’s coverage of Compliance 2014.  Thank you for following our updates from the event throughout the day.  Follow MFA on Twitter to keep up on the news from MFA and the global hedge fund industry.